STK32C

Across TCGA pan-cancer cohorts, STK32C mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated STK32C data layer compared with 24 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher STK32C mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated STK32C expression acts as an unfavorable survival marker, although some lineages such as HNSC and GBM show a favorable association.

UCEC, LUAD, and LSCC are the cancer types where STK32C mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	II,III,IV	0.537	1.000	.008	12	view →
LUAD	OS	Median	II,III,IV	0.429	0.911	.008	7	view →
LSCC	OS	Median	II,III,IV	0.675	0.882	.025	4	view →
HNSC	OS	Quartile	IV	0.829	0.511	.019	2	view →
GBM	DFS	Tertile	All	0.841	0.668	.049	1	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

STK32C–UCEC (OS)

Open the UCEC breakdown →